From Frustration to Hope: The Klein Family’s Search for Effective Autism Treatment
For many families, the path to cannabinoid medicine begins after years of trying pharmaceuticals that offer little relief. Shifra and Alex Klein, an Orthodox Jewish couple living in Los Angeles, experienced this cycle firsthand while seeking help for their son’s severe autism. After exhausting conventional therapies and medications prescribed by UCLA specialists, they began to look for a more holistic solution.
Turning to CBD After Pharmaceutical Dead‑Ends
The Kleins initially approached their child’s neurologists at UCLA with the idea of using cannabis‑derived CBD as an adjunct therapy. The clinicians, bound by prevailing medical caution and limited clinical data at the time, declined to authorize the treatment. Undeterred, the couple decided to investigate the plant on their own, motivated by a desire to know exactly what they would be giving their son.
Having never used cannabis themselves, Shifra and Alex prioritized transparency. They wanted full disclosure of the oil’s origin, extraction method, and third‑party lab results. After months of researching extraction techniques, reviewing state regulations, and networking with local dispensaries, they concluded that the only way to guarantee a product that met both safety and kosher standards was to produce it themselves.
DIY Extraction and Early Success
The couple began by making simple edibles at home, using flower purchased from licensed Los Angeles dispensaries. Alex recalls the first visit to a dispensary feeling out of place: a security guard with tattoos and a biker‑style appearance mistook his Orthodox appearance for a tourist looking for a nearby temple. Once Alex started asking specific questions about strains such as AC/DC and Harlequin—varieties known for balanced CBD‑THC profiles—the guard’s demeanor shifted, and a productive conversation ensued.
Through trial and error, the Kleins refined a low‑heat extraction process using a household Crockpot. Each batch was sent to an independent laboratory for potency and contaminant screening. When a formulation finally passed rigorous testing, they infused it into cookies and administered a small dose to their son. The effects were noticeable within hours: improved eye contact, longer attention span, clearer verbal attempts, and smoother motor coordination. Friends and community members who observed the changes began requesting the oil for their own families.
Creating the First OU‑Certified Kosher CBD Brand
Word of the Klein’s homemade CBD spread quickly within the Los Angeles Orthodox community. Demand grew to the point where Shifra found herself spending more time producing oil than attending her regular job. Recognizing a broader need, the couple formalized their effort in 2017 by launching Mitzva Wellness, aiming to become the first kosher‑certified CBD brand under the Orthodox Union (OU).
The OU, the largest and most respected kosher certifying agency worldwide, had never approved a cannabis‑derived product. Achieving certification required nearly eight months of education: the Kleins provided detailed documentation on cultivation practices, extraction solvents, laboratory testing protocols, and the removal of any non‑kosher additives. They also addressed common misconceptions about cannabis, emphasizing that the final product contained isolated CBD with no psychoactive THC.
In early 2018, Mitzva Wellness received the OU’s kosher seal—a milestone that opened doors to pharmacies, wellness centers, and doctors’ offices across the United States. The brand’s product line now includes:
- CBD tinctures formulated with precise terpene blends for sleep, focus, and calm.
- Topical salves infused with kosher‑certified terpenes for localized discomfort.
- Specialty terpene tinctures designed to target specific symptoms based on peer‑reviewed research.
All items are subjected to third‑party testing for potency, heavy metals, pesticides, and microbial contamination, with results accessible via batch numbers on the company website.
Efficacy Driven by Science‑Based Terpene Profiles
Mitzva Wellness distinguishes itself by formulating products around specific terpene combinations that have demonstrated therapeutic promise in scientific literature. For example, a blend of β‑caryophyllene and linalool—terpenes shown to modulate anxiety and inflammation in animal models (see Frontiers in Pharmacology, 2019)—is featured in their “Calm” tincture. Another formula pairs limonene with pinene, aiming to support alertness and mood, based on clinical observations reported in Journal of Clinical Psychopharmacology, 2018.
By anchoring product development in peer‑reviewed studies, the Kleins aim to provide consumers with options that go beyond generic CBD isolate, addressing the entourage effect where cannabinoids and terpenes work synergistically.
A Commitment to Community and De‑Stigmatization
The name “Mitzva” translates to “good deed” in Hebrew, reflecting the couple’s mission to give back. Ten percent of monthly sales are donated to nonprofit organizations that support families affected by neurological conditions, veteran services, and first‑responder wellness programs. Additionally, Mitzva offers discount plans for healthcare workers, firefighters, and law‑enforcement personnel.
Beyond philanthropy, the Kleins actively engage in community outreach. They host informational webinars, answer dosing questions, and help individuals locate physicians experienced in cannabinoid therapeutics. Their efforts have contributed to a gradual shift in perception within the Orthodox Jewish world, where cannabis was once viewed almost exclusively through a lens of prohibition.
Alex notes that many people who could benefit from cannabinoid therapy still hesitate because of lingering stigma. By sharing their personal journey—complete with laboratory reports, kosher certification, and transparent sourcing—the Kleins hope to model a responsible, evidence‑based approach that encourages informed decision‑making.
Looking Ahead: Expanding Access and Research
Shifra identifies geographic expansion as a near‑term goal. “Being able to reach other places in California is a really huge goal for us,” she says. “When Mitzva Wellness can be available in more locations, we can help more families access safe, tested CBD options.”
The company continues to collaborate with academic researchers to refine terpene‑rich formulations and to collect real‑world outcome data from patients using their products. Such initiatives not only strengthen the brand’s scientific credibility but also generate valuable insights that can inform broader medical guidelines.
For anyone curious about the intersection of faith, science, and plant‑based medicine, Mitzva Wellness offers a transparent, kosher‑certified pathway grounded in both personal experience and rigorous testing.
Find the original story that inspired this overview Here
